as shown by the increase in SOST mRNA levels, the gene encoding sclerostin, upon treatment of the recipient mice with AzadC. This also confirms, in vivo, the role of DNA methylation in the regulation of SOST expression previously shown in vitro. Altogether our results show that these immortalized cell lines constitute a particularly useful model system to obtain further insight into bone homeostasis, and particularly into the epigenetic mechanisms regulating sclerostin production.
Introduction
As is the case with other primary cells, primary osteoblasts undergo a finite number of cell divisions in culture before they enter a state known as replicative senescence [1] , where they can no longer divide. Therefore, the use of primary cell lines would require constant re-establishment of fresh cell cultures from explanted tissue, a process that can introduce significant variability in research studies [2] . In addition, primary human bone cells often show alterations of their phenotypic characteristics with increasing passage number. Other model systems, such as osteoblastic cell lines of rodent origin [3, 4] or human osteosarcoma cell lines [5] , have been used to try to avoid this problem. However, all these systems have specific limitations. The use of cells derived from bone tumors is not advisable, as we cannot entirely be aware of the nature of the events that drove the oncogenic transformation, or whether these modifications affect their original phenotype. Furthermore, the response capacity of these osteosarcoma cell lines to growth hormones and other factors might also be altered. Regarding the osteoblastic lines Abstract Different model systems using osteoblastic cell lines have been developed to help understand the process of bone formation. Here, we report the establishment of two human osteoblastic cell lines obtained from primary cultures upon transduction of immortalizing genes. The resulting cell lines had no major differences to their parental lines in their gene expression profiles. Similar to primary osteoblastic cells, osteocalcin transcription increased following 1,25-dihydroxyvitamin D 3 treatment and the immortalized cells formed a mineralized matrix, as detected by Alizarin Red staining. Moreover, these human cell lines responded by upregulating ALPL gene expression after treatment with the demethylating agent 5-aza-2′-deoxycytidine (AzadC), as shown before for primary osteoblasts. We further demonstrate that these cell lines can differentiate in vivo, using a hydroxyapatite/tricalcium phosphate composite as a scaffold, to produce bone matrix. More importantly, we show that these cells respond to demethylating treatment, of rodent origin, their limitations come from the existence of species-specific characteristics. To overcome these problems, researchers have developed human primary osteoblastic cell lines with extended replicative capacity [6, 7] . In order to become useful in experimental models, these cells should not only be able to increase the number of cell divisions that they can undergo in culture, but they also require the genotypic and phenotypic characteristics of the cell line to be preserved throughout the expansion process.
We have previously shown that the expression of key genes regulating human bone homeostasis, such as SOST (encoding sclerostin), ALPL (encoding alkaline phosphatase), RANKL (encoding the receptor activator of nuclear factor kappa-B ligand) and OPG (encoding osteoprotegerin), is controlled by changes in the methylation status of specific CpG islands located at regulatory regions [8] [9] [10] . Despite their popularity, in our hands, osteoblastic cell lines of murine origin do not adequately reproduce the effect of demethylating agents in human systems, highlighting the importance of developing human cell lines that respond to this kind of treatment in order to allow us to study their effect in vivo.
Here, we describe two new osteoblastic cell lines and compare them with already available osteoblastic cell lines and primary osteoblasts. The new cell lines maintain common markers of primary osteoblastic cells and are able to differentiate and mineralize in vitro. More importantly, these two cells lines are capable of responding to the demethylating agent 5-aza-2′-deoxycytidine (AzadC) not only in vitro, but also in vivo when transplanted into nude mice.
Materials and methods

Isolation of primary osteoblasts and cell cultures
Primary human osteoblasts (hOBs) were isolated from femoral heads obtained from donors undergoing hip replacement surgery due to osteoarthritis or hip fractures, as previously described [10] . In brief, small bone fragments obtained by mechanical rupture of the femoral head were washed with phosphate-buffered saline (PBS) to remove bone marrow. After washing, bone fragments were seeded onto a T175 flask and cells were allowed to grow for 10 days in standard conditions (5 % CO 2 , 37 °C) before the first medium change. When 80 % confluence was reached, cells were trypsinized and used for different experiments. Dulbecco's modified Eagle's medium (DMEM; Invitrogen) was used with 10 % fetal bovine serum (FBS) and 1 % penicillin/streptomycin.
The human osteosarcoma cell line MG-63 was routinely cultured in DMEM supplemented with 10 % FBS and antibiotics. The human osteoblastic cell line HOS-TE85 was maintained in culture with Eagle's minimum essential medium (Sigma-Aldrich) supplemented with 10 % FBS and antibiotics.
For 1,25-dihydroxyvitamin D 3 (1,25(OH) 2 D 3 ) treatment, this factor was added to the culture medium at a final concentration of 10 −8 M for 48 h. To induce osteoblastogenesis, the cells were switched to osteogenic medium containing 50 μM ascorbic acid, 1 μM dexamethasone and 10 mM β-glycerophosphate for up to 4 weeks. The medium was changed every 3 days. In order to stain calcium deposits, wells were rinsed with PBS, fixed in 70 % ethanol for 1 h and then rinsed with water. For the staining, 40 mM Alizarin Red was added to the wells for 15 min. Excess solution was rinsed off with water and allowed to air-dry [10] .
For demethylation experiments, all cells were plated at 5,000 cells/cm 2 and treated for 4 days in the presence of 1 or 5 μM AzadC (Sigma-Aldrich) prior to analysis of gene expression.
Immortalization
For immortalization, primary cells expanded up to 3 passages were seeded onto 6-well plates and infected with four different self-inactivating lentiviruses. These lentiviruses drive the expression of the following transgenes-(1) SV40 large T antigen, (2) c-myc, (3) E7, and (4) Id2 (sequences are available on request) from an SV40 promoter. The primary cells were infected overnight in the presence of 8 μg/ ml polybrene. After 12 h, the culture medium containing the lentiviruses were aspirated and fresh cultivation medium was added to the cells. Afterwards the cultivation medium was renewed every 2-3 days for the next 3 weeks until colonies of proliferating cells became apparent. These proliferative colonies were pooled and further expanded.
Immortalized cell lines are available upon request.
In vivo experiments
The in vivo formation of bone matrix was studied following the experimental model proposed by Mankani et al. [11, 12] . FoxN1 nu athymic nude mice were purchased from Harlan Laboratories and housed in a barrier facility according to animal care standards established by the European Union. All the experiments were reviewed and approved by the Animal Care Committee at the University of Cantabria.
Hydroxyapatite/tricalcium phosphate (HA/TCP) composites (Scaffdex) used as scaffold were purchased from Sigma. Prior to implantation in the mice, 30-40 mg of the pulverized composite, previously sterilized by autoclaving, were incubated with 1.5-2 million cells in 1 ml of serumfree culture medium in an Eppendorf tube. Incubation was performed at 37 °C with rotation for 90 min. After incubation, the tube was centrifuged briefly and excess medium 1 3 was removed. The composite cell mixture was then placed subcutaneously in the back of an athymic nude mouse using a Jamshidi-type needle (2 mm internal diameter). Some mice were treated with AzadC (700 mg/kg per week divided into 3 doses, injected intraperitoneally).
Once removed from the mice, implants were fixed in 10 % formaldehyde for 3 days at 4 °C and decalcified in 20 % EDTA in PBS (pH 7.4) for 4 weeks at 4 °C with two weekly changes of the EDTA solution. After decalcification, implants were embedded in paraffin. Five-micron sections were stained with hematoxylin/eosin (H&E) [13] , Masson-Goldner trichrome [14] or Sirius Red [15] following standard protocols.
Immunohistochemistry
After removing paraffin and rehydration through decreasing concentrations of alcohol solutions and water, antigens were unmasked by exposing the slides to a 10 mM solution of sodium citrate pH 6.0 for 15 min. To quench endogenous peroxidase activity, sections were treated with 3 % hydrogen peroxide in methanol for 10 min. After extensive washing with PBS for 20 min, and exposure to a blocking solution (TBST + 5 % goat serum) for 1 h, the samples were incubated overnight with a 1/200 solution of the anti-collagen antibody anti-collagen type I alpha 1 (COL1A1) (ab34710; Abcam, Cambridge, UK) in blocking buffer. Samples were then incubated with a secondary antibody (biotinylated affinity purified goat anti-rabbit IgG) diluted in blocking solution for 1 h, followed by 3,3′-diaminobenzidine, horseradish peroxidase, and counterstaining with hematoxylin.
Electron microscopy
For ultrastructural examination of the extracted implants, samples were submerged into 1 % paraformaldehyde and 1 % glutaraldehyde in 0.1 M phosphate buffer, pH 7.4. Subsequently samples were rinsed in 0.1 M phosphate buffer, postfixed in 2 % osmium tetroxide, dehydrated in acetone and embedded in araldite (Durcupan; Fluka, Switzerland). Ultrathin sections stained with uranyl acetate and lead citrate were examined with a JEOL 201 electron microscope.
Gene expression and SOST methylation analyses
RNA isolation from cell cultures and removed implants and cDNA synthesis were performed as previously described [16] . Gene expression levels were measured by quantitative real-time polymerase chain reaction (qPCR) using Taqman assays (Life Technologies). Expression levels were calculated relative to the TATA Box Binding Protein gene (TBP) or GAPDH as 2 − C t . SOST promoter methylation status was determined by quantitative methylation-specific PCR (qMSP), as previously reported [8] .
Alkaline phosphatase activity assay
To measure alkaline phosphatase activity, the cells were plated at 25,000 cells/cm 2 and cultured for 3 days in DMEM. Then medium was removed and the cell layer rinsed twice with cold sterile PBS. The cells were lysed with cold 0.05 % Triton X-100 and sonicated for 10 min. Measurements of alkaline phosphatase activity were performed as previously described [10] .
Statistical analysis
Statistical significance was determined by Student's t test. Data are presented as mean ± standard error of the mean values.
Results
Morphological and transcriptional characterization of the immortalized cell lines
The primary osteoblastic cultures were isolated from the femoral head of an osteoarthritic patient subjected to hip replacement and a patient that suffered an osteoporotic hip fracture. The two immortalized cell lines derived from osteoblasts obtained from these two patients were named OB50Li and OB52Li, respectively.
After isolation and expansion of the primary cells, they were transduced with four different lentiviral vectors encoding for (1) SV40 large T antigen (TAg), (2) c-myc, (3) E7, and (4) inhibitor of DNA binding 2 (Id2), a dominant-negative helix-loop-helix protein. These genes were identified in a previous screen as factors that facilitate the immortalization of primary hOBs (Lipps et al., submitted). For selection of transduced primary cells, we used the difference in proliferation capacity between the primary hOBs (low proliferation capacity) and the infected cells (high proliferation capacity) and maintained the infected cells for 3 weeks with regular medium exchange until colonies of proliferating cells arose. The individual colonies of immortalized cells were then pooled and further expanded. The resulting polyclonal cell lines showed robust proliferation and were truly immortalized, as they could be cultivated for >100 cumulative population doublings showing no signs of senescence.
The cell morphology of the OB50Li and OB52Li cell lines under phase-contrast microscopy was clearly different from that of the original primary cell lines. While the primary cells showed the typical spindle-shape appearance, the immortalized cell lines showed a polygonal shape (Fig. 1a) . The immortalized cell lines typically grew from the initial cell colonies in a sheet-like pattern until confluence was reached.
To determine which conditions promote a more sustained growth of these cells lines, immortalized cells were seeded in cultures containing different percentages of FBS. The proliferation of the two cell lines was enhanced in medium with increasing concentrations of serum between 1 and 10 % (Fig. 1b) . Both lines proliferated stably until they reached confluence, although the OB52Li cell line seemed to be slightly less proliferative with a higher doubling time (12.5 h for OB50Li vs 14.5 h for OB52Li).
The osteogenic nature of the cell lines can be characterized in vitro by assessing the expression of temporally regulated osteogenic markers. Mature osteoblasts produce bone matrix constituents such as osteocalcin (encoded by BGLAP) [17] . Osteoblasts also regulate bone matrix mineralization [18] through the production of large amounts of alkaline phosphatase, encoded by the ALPL gene [19] . Expression analysis of the genes encoding these two proteins revealed that the two immortalized cell lines expressed both osteogenic markers, although to a different extent (Fig. 1c) . BGLAP expression levels were similar in the immortalized cell lines and in nontransformed primary hOBs. In fact, the expression levels of the two immortalized cell lines seemed to be more similar to those of the primary osteoblasts than those of the MG-63 cell line. Regarding ALPL, the expression level of this gene in primary osteoblasts was considerably higher than that in the osteoblastic cell line MG-63, as we have previously described [10] (Fig. 1c) (Fig. 1d) .
In vitro response to the demethylating agent AzadC and to vitamin D
In agreement with previous reports using primary osteoblasts [10] , we observed that ALPL expression by the OB50Li and OB52Li cell lines increased significantly in response to AzadC (p < 0.05 vs baseline for all cell types), thus showing that the response to this inhibitor of DNA methyltransferases is indeed preserved in the OB50Li and OB52Li cell lines (Fig. 2a) . The vitamin D active metabolite 1,25(OH) 2 D 3 is one of the main endocrine factors regulating bone homeostasis. It can regulate the activity of both bone-forming cells (osteoblasts) and bone-resorbing cells (osteoclasts) [20] . 1,25(OH) 2 D 3 is known to control osteoblast proliferation, differentiation and mineralization [21] by inducing the production of alkaline phosphatase [22] [23] [24] [25] [26] and osteocalcin [27, 28] .
We cultured the immortalized osteoblastic cell lines in the presence and absence of 1,25(OH) 2 D 3 and analysed the expression of BGLAP, the gene encoding osteocalcin, which is involved in the mineralization process (Fig. 2b) . qPCR analysis demonstrated, in both cell lines, an upregulation of the osteoblastic marker BGLAP in response to 1,25(OH) 2 D 3 , which is consistent with previous results obtained in primary osteoblasts [29] .
Mineralization
In order to check whether these immortalized cell lines were able to produce an osteoid-like mineralized matrix, we incubated confluent hOBs and immortalized osteoblasts for 28 days in an osteogenic culture medium and determined their mineralization potential by Alizarin Red staining at different time points (Fig. 2c) . Figure 2c clearly shows that both immortalized cell lines are able to form a mineralized matrix in response to stimuli-inducing osteogenic differentiation. ALPL is mainly expressed during the initiation of the mineralization process and is soon observed on the cell surface; however, its expression declines later in the developmental program. Consistent with this, we found a decrease in the expression levels of ALPL during the mineralization process (Fig. 2d) , which is also consistent with previous reports in primary osteoblasts [10] .
The final stage of osteoblast differentiation is also accompanied by the upregulation of genes more characteristic of the osteocyte phenotype, such as SOST, encoding sclerostin, or the gene encoding the fibroblast growth factor 23 (FGF23). Similar to the results previously obtained with primary osteoblasts, none of these transcripts were detectable by qPCR in either the nontransformed or the immortalized osteoblasts (data not shown). This was in agreement with a comparable degree of hypermethylation of the SOST promoter (>80 %) in primary osteoblasts and the immortalized cell lines.
Analysis of the bone-forming activity of the immortalized osteoblastic cell lines in vivo
In order to assay the bone-forming capacity of the OB50Li and OB52Li lines in vivo, both cell lines were seeded onto an HA/TCP scaffold prior to subcutaneous implantation in FoxN1 nu athymic nude mice. As a control, we also performed the same procedure with hOBs and the osteosarcoma cell line HOS-TE85. After 3 months, the implants were surgically removed and the extent of new bone formation was analysed by gene expression and histological techniques. It is important to note that no tumor formation was observed in the nude mice after the 3-month period, demonstrating that the novel cell lines are immortalized but not oncogenically transformed.
H&E staining revealed the existence of cell infiltrations between the scaffold particles. The scaffold pores contained a large number of cells distributed throughout the scaffold and/or bone matrix, irrespective of the cell type initially seeded in the scaffold (Fig. 3a, H&E column) . Immunohistochemistry analysis also showed that all implants were immunoreactive for collagen type I (Fig. 3a , IHQ COL1A1 column) with very low background labeling, although its presence was more noticeable in the case of the primary osteoblasts and the immortalized cell lines OB50Li and OB52Li (Fig. 3a, IHQ COL1A1 column) . This was also shown using the Masson-Goldner technique (Fig. 3a, Masson column) , a widely used histological technique that stains collagen in a blue/green color. Bone-type matrix was not very abundant and looked somewhat immature, but immortalized cells and primary nontransformed cells laid similar amounts of matrix. Interestingly, observation of the implants at higher magnification revealed some cells embedded within the matrix and surrounded by a clear region, resembling the morphology of osteocytes within osteocytic lacunae (Fig. 3b) .
The samples were stained with Sirius Red to observe the disposition of collagen fibers under polarized light. In Fig. 4a , it is possible to observe clear bright areas that would correspond to the birefringence of collagen fibers structured in an antiparallel disposition, characteristic of organized lamellar bone. Additionally, the autofluorescence of bone was also detected in these samples when observed under green fluorescent light (Fig. 4b) .
Electron microscopy studies confirmed the presence of collagen fibers laid in an antiparallel orientation (Fig. 4c1) , dense mineralization vesicles (Fig. 4c2) , cells embedded in the collagen matrix (Fig. 4c3) , and polarized osteoblasts with extensive rough endoplasmic reticulum (Fig. 4c4) .
To analyse the in vivo osteogenic signature of the immortalized cells, we isolated mRNA from the implants and carried out qPCR analysis for the osteogenic markers ALPL, COL1A1 and SOST using oligonucleotides specific for the detection of the human genes. ALPL and SOST were expressed in implants of both immortalized cell lines, although to a different extent, as shown in Fig. 5a . Furthermore, confirming the histological results, the expression of COL1A1 was detected in the implants. 
In vivo response to the demethylating agent AzadC
In our hands, osteoblastic cell lines of murine origin do not adequately reproduce the effect of demethylating agents in human systems. We tested whether the immortalized cell lines were able to respond to treatment with the demethylating agent AzadC in vivo. For this purpose, mice harboring implants were treated with AzadC for a month.
Control mice were injected with an equivalent volume of saline solution (Fig. 5b) . As shown in Fig. 5c , treatment with AzadC significantly increased the expression levels of sclerostin in both immortalized cell lines and in the human osteosarcoma cell line HOS-TE85 to a similar level. In agreement with this, by using qMSP we confirmed that methylation of the promoter of the SOST gene was decreased by AzadC treatment (not shown). 
Discussion
Osteoporosis is a disorder characterized by a low bone mass. It results from the uncoupled activity of bone-resorbing osteoclasts and bone-forming osteoblasts. Given the high prevalence of osteoporosis among postmenopausal women and older men, intense research is ongoing in order to get a deeper understanding of the disease pathogenesis and to discover new drug targets. In fact, although potent anti-resorbing drugs are available, the armamentarium to stimulate bone formation is much more limited. Hence, there is a strong interest in the development of experimental models that would allow us to effectively screen interventions promoting bone formation.
Osteoblasts are responsible for the formation of new bone and therefore a tight control of their activity is essential for skeletal homeostasis. A variety of cell lines from murine and human origins have been described and are frequently used, along with primary osteoblasts, as models to study osteoblast activity. However, given the rapid loss of the replicative potential of primary hOBs, there is a need for alternative models. On the other hand, spontaneously immortalized human osteoblastic cell lines may accumulate a number of DNA changes and they may not adequately preserve the normal phenotype. In this study, we describe the generation and characterization of two new human osteoblastic cell lines that were immortalized by the controlled transfection of a set of survival genes. They had a number of characteristics resembling those of normal osteoblasts, including the expression of genes typical of osteoblasts and the ability to form an osteoid-like matrix, both in vitro and in vivo.
We showed that these cells appeared to preserve many of the characteristics of primary osteoblasts. They are able to proliferate normally and express typical osteogenic markers, such as BGLAP and ALPL. Indeed BGLAP expression [32, 33] . Moreover, when maintained in an osteogenic culture medium the two immortalized cell lines are able to form a mineralized matrix. This is concomitant with the downregulation of ALPL, a marker whose expression is known to decrease rapidly during the mineralization process, as shown in primary osteoblast cultures. However, we were not able to detect the expression of osteocyte specific genes, such as SOST or FGF23, in cultures of the immortalized cells lines maintained for several weeks in vitro. Similarly, these genes were not detected in long-term cultures of primary osteoblasts. These results suggest that current in vitro models are not able to induce terminal differentiation of osteoblasts into osteocytes. Notably, the two cell lines are able to produce bone matrix in vivo, when cells are seeded in a HA/TCP scaffold and implanted in extra-skeletal tissues of athymic nude mice. For bone tissue to develop from cells implanted in vivo, a scaffold is needed to provide both a surface and a space for the growth of new cells. HA/TCP particles mimic the natural bone matrix in humans and have been shown to provide an appropriate environment for the growth of bone tissue [34] [35] [36] . Analysis by qPCR confirmed the expression of different bone markers in the implants seeded with the immortalized cells lines. These results confirm that HA/ TCP scaffolds can support the growth of the immortalized cell lines, and that these cell lines can differentiate to produce human bone matrix in vivo.
Recent findings have shown that DNA methylation of regulatory regions is an essential mechanism controlling expression of osteogenic genes. Of particular interest is the regulation of SOST, the gene encoding sclerostin, an important inhibitor of bone formation. However, in our hands, mouse immortalized osteoblastic cell lines do not seem to respond in vivo to the demethylating agent AzadC and, therefore, are not a good model to study the regulation of osteoblast differentiation by DNA methylation in general, and SOST/sclerostin regulation in particular. Importantly, we have shown that the two immortalized cell lines presented here are able to respond in vivo to treatment with AzadC by upregulating SOST expression. Sclerostin is a critical factor in the regulation of bone formation. In fact, neutralizing anti-sclerostin antibodies are being developed as a new therapy for osteoporosis [37, 38] . However, the mechanisms regulating sclerostin expression are not well established. This is largely due to the fact that sclerostin production is limited to osteocytes and to the absence of human osteocytic cell lines. The fact that our immortalized cell lines respond to AzadC treatment by upregulating the expression of the SOST gene after transplantation into nude mice confirms previous results in vitro and makes these cell lines useful models to study the regulatory effects of DNA methylation on cells of the osteoblastic lineage in vivo.
